Sanofi is here to support you and your patients.

Ask us your questions about our products, patient materials or organising a meeting.

Yes, I'd like support

Curated Science

Prescribing Infomation can be found through the links in the Product Cards at the bottom of the page

SPARTA study | Toujeo® (Insulin Glargine 300 units/mL)

Video: BRIGHT study | Toujeo® (Insulin Glargine 300 units/mL)

InRange Study | Toujeo® (Insulin Glargine 300 units/mL)

T1 Evidence in Adults | Toujeo® (Insulin Glargine 300 units/mL)

T1DM - Meta-Analysis | Toujeo® (Insulin Glargine 300 units/mL)

T1 Evidence in Children aged 6 years and above | Toujeo® (Insulin Glargine 300 units/mL)

T1 Edition Junior Study | Toujeo® (Insulin Glargine 300 units/mL)

ORION Observational Study | Toujeo® (insulin glargine 300 units/mL)
SEE EVERYTHING

Diabetes Products

ADMELOG
insulin lispro

Prescribing Information GB

GB ONLY CONTENT

MAT-XU-2302443 (v1.0)
Date of preparation: June 2023

LANTUS
insulin glargine

Prescribing Information GB
Prescribing Information NI

MAT-XU-2201444 (v3.0)
Date of preparation: January 2023

TOUJEO
insulin glargine

Prescribing Information GB
Prescribing Information NI

MAT-XU-2302426 (v6.0)
Date of Preparation: October 2023 

TRURAPI
insulin aspart

Prescribing Information GB
GB ONLY CONTENT

MAT-XU-2205461 (v7.0)
Date of preparation: June 2023

MAT-GB-2200621 (v4.0)
Date of preparation: November 2023